Orily Pratt  Strategy and Marketing

EVOLENCE injectable filler, developed by ColBar LifeScience Ltd., utilizes the GLYMATRIX technology to create a professionally administered, injectable treatment for soft tissue deficiencies, especially facial wrinkles. In 2006 EVOLENCE was purchased by Johnson & Johnson, and gained FDA approval in 2007.
Despite the fierce competition in the aesthetic medicine field, EVOLENCE has managed to establish a significant position among its adversaries, and has become a necessary part of the aesthetic clinic portfolio.

Project included:

• Global marketing plan

• Naming and brand positioning

• Visual identity

• Marketing collateral

• Online presence

• Training and education

• Advisory board management

• Exhibitions and industry events

• PR activities

Project partners:

• Wolff Olins branding

• Jason&Jason Visual Communications

• Ozone Communications

• Miri Davidovitz photography

• Gerber Communications

• Tal Arazi Visual Communications

• Wells Healthcare

• AR Print

• RM Studio

• YKM web design

• InterbrandWood NY